share_log

Moderna开发mRNA疫苗再获批准

Gelonghui Finance ·  Aug 24 01:39

格隆汇8月24日|Moderna宣布,欧盟委员会(EC)已批准其呼吸道合胞病毒(RSV)mRNA疫苗mRESVIA(mRNA-1345)上市,用于保护60岁及以上的成年人免受RSV感染引起的下呼吸道疾病(RSV-LRTD)。Moderna目前已向全球多个监管单位提交了mRNA-1345的上市许可申请。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment